Regeneron Pharma (REGN) PT Lowered to $812 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Buy this U.S. large-cap biopharma stock: JPMorgan
August 11, 2025 6:00 PM EDTJPMorgan told investors in a note Monday that Eli Lilly & Co. (NYSE: LLY) shares are its top pick among U.S. large-cap biopharma names after second-quarter earnings.
While orforglipron ph3 obesity weight loss data fell just short of expectations, we continue to see a clear role for the product in the market while LLYs core injectable incretin franchise remains optimally positioned,... More
